Form 4: Opko Health Sells Shares in GeneDx Holdings Corp.

Opko Health, a significant shareholder in GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in a series of transactions.

Summary

• Opko Health, Inc., a major shareholder of GeneDx Holdings Corp. (WGS), has reported the sale of Class A Common Stock.
• The sales occurred over three days: August 15, 2024, August 16, 2024, and August 19, 2024.
• On August 15, 2024, 39,824 shares were sold at a weighted average price of $33.0832 per share.
• On August 16, 2024, 50,000 shares were sold at a weighted average price of $34.297 per share.
• On August 19, 2024, 50,000 shares were sold at a weighted average price of $34.4904 per share.
• Following these transactions, Opko Health directly owns 2,646,972 shares of GeneDx Holdings Corp.'s Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports the sale of shares. It doesn't indicate a positive or negative outlook for either company.

Industry Context

This activity is typical for major shareholders and could be part of a broader portfolio management strategy or reflect Opko Health's view on the valuation of GeneDx.

Stakeholder Impact

• The sale of shares by a major shareholder like Opko Health could potentially influence investor sentiment towards GeneDx Holdings Corp.

Key Dates